| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Takeda Pharmaceutical Co Ltd is a 10% Owner at OVID, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 51 sales. Those positions are worth an estimated $30.4M at current prices.
Our model assigns Takeda Pharmaceutical Co Ltd a strong insider score of 70/100, based on 40 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +9.9%.
Takeda Pharmaceutical Co Ltd's largest disclosed position is in PHAT as 10% Owner, worth about $30.4M. The recent filings there lean toward selling, a net 4,916,417 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 3,293 | $35.19 | $115,882.76 | -0.3% | - | - | |
| Jun 8, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 2,364 | $35.05 | $82,853.20 | -0.3% | - | - | |
| Jun 2, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 4,300 | $35.18 | $151,274.00 | -0.5% | - | - | |
| Jun 1, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 20,116 | $35.96 | $723,434.21 | -2.1% | - | - | |
| May 27, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 20,811 | $36.84 | $766,699.64 | -2.1% | - | - | |
| May 25, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 21,541 | $35.93 | $773,888.84 | -2.1% | - | - | |
| May 21, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 18,746 | $35.50 | $665,439.32 | -1.8% | -13.2% | -75.6% | |
| May 14, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 100 | $35.00 | $3,500.00 | - | - | - | |
| May 13, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 11,876 | $35.44 | $420,891.99 | -1.1% | - | - | |
| May 7, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 1,011 | $35.03 | $35,415.33 | - | - | - |